Asadullina, D.D.,
Gilyazova, I.R.,
Ivanova, E.A.,
Izmailova, S.M.,
Gilyazova, G.R.,
Pavlov, V.N.,
Khusnutdinova, E.K. (2024) inhibitors (ICI) still have limited therapeutic efficacy. A growing number of investigations has demonstrated
CAI, B.,
MA, W.,
WANG, X.,
SUKHAREVA, N.,
HUA, B.,
ZHANG, L.,
LI, X.,
LI, S.,
LIU, S.,
YU, M.,
XU, Y.,
SONG, R.,
XU, B.,
YANG, F.,
HAN, Z.,
DING, F.,
HUANG, Q.,
YU, Y.,
ZHAO, Y.,
WANG, J.,
BAMBA, D.,
PAN, Z.,
YANG, B.,
XU, J.,
ZAGIDULLIN, N.,
LI, F.,
TIAN, Y. (2020) ) phosphorylation and reduced its nuclear translocation by binding PP1A. Verteporfin, a YAP1
inhibitor decreased Lnc
CIRCULATING MICRORNA AS
NOVEL POTENTIAL BIOMARKERS FOR THE DIAGNOSIS OF HIGHLY MALIGNANT GLIOMAS